The phenotypic data presented in Figure 2 showed that tumor infiltrating T cells progressively lost expression of CD27 during the course of tumor regression, while CD27 expression on T cells in peripheral lymphoid organs remained high. This evidence concerns the gene CD27 and neoplasm.